Todays Report: The Monsanto Co. (MON) Given “Outperform” Rating at BMO Capital Markets

The Monsanto Co. (MON) Given “Outperform” Rating at BMO Capital Markets

BMO Capital Markets restated their outperform rating on shares of Monsanto Co. (NYSE:MON) in a report published on Saturday morning. BMO Capital Markets currently has a $128.00 price objective on the stock.

Other equities analysts have also recently issued reports about the company. Piper Jaffray Cos. reiterated an overweight rating and set a $127.00 price target (up from $95.00) on shares of Monsanto in a report on Monday, June 13th. Zacks Investment Research cut Monsanto from a hold rating to a strong sell rating in a report on Friday. Argus reiterated a buy rating and set a $128.00 price target (up from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $122.43 price target for the company in a report on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the company a sell rating in a report on Monday, June 27th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of Buy and an average target price of $114.67.

Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm has a market cap of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. The firm has a 50-day moving average price of $104.86 and a 200 day moving average price of $101.43. Monsanto has a one year low of $83.73 and a one year high of $114.26.

Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. The business earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.19) EPS. On average, analysts forecast that Monsanto will post $4.89 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.

In related news, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.

Several hedge funds have recently bought and sold shares of MON. FMR LLC increased its stake in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Third Point LLC acquired a new stake in Monsanto during the second quarter worth $206,820,000. Carmignac Gestion acquired a new stake in Monsanto during the second quarter worth $197,555,000. TIAA CREF Investment Management LLC increased its stake in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock worth $481,732,000 after buying an additional 1,560,646 shares during the period. Finally, Adage Capital Partners GP L.L.C. increased its stake in Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock worth $176,327,000 after buying an additional 1,147,200 shares during the period. Hedge funds and other institutional investors own 79.02% of the company’s stock.

About Monsanto

Related posts

Leave a Comment